Article
BRAVE: a highly accurate method for predicting HIV-1 antibody resistance using large language models for proteins
2025-07-31
Abstract excerpt
<h4>Motivation</h4> Broadly neutralizing antibodies (bNAbs) that target the envelope glycoprotein (Env) of human immunodeficiency virus-1 (HIV-1) have been utilized in clinical trials aimed at preventing and treating HIV-1 infections. However, the emergence of neutralization resistance to bNAbs occurs rapidly due to the high mutation rate of HIV-1. Previous studies have suggested the use of in silico methods to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ab4b0738-bb4d-50c1-99a4-1c4a53414d90
- DOI
- 10.1101/2025.07.28.667234
